Xenetic Biosciences, Inc. Net Income Loss

• Xenetic Biosciences, Inc. showed an increase of +32.3% in Net Income Loss from 2024 to 2025.
• This data is from Xenetic Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2011 to 2025), Xenetic Biosciences, Inc.'s Net Income Loss has declined by 1,967.4%.
• Historical annual values: Fiscal year 2025: -$2.68 million | Fiscal year 2024: -$3.96 million | Fiscal year 2023: -$4.13 million | Fiscal year 2022: -$6.55 million | Fiscal year 2021: -$5.65 million | Fiscal year 2020: -$10.89 million | Fiscal year 2019: -$12.78 million | Fiscal year 2018: -$7.30 million | Fiscal year 2017: -$3.60 million | Fiscal year 2016: -$54.21 million | Fiscal year 2015: -$12.51 million | Fiscal year 2014: -$14.31 million | Fiscal year 2013: -$8.58 million | Fiscal year 2013: -$89.2 thousand | Fiscal year 2012: -$89.2 thousand | Fiscal year 2011: -$129.7 thousand.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026